BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...Andres Sirulnik as CMO. Joe was a VP of oncology Sanofi (Euronext:SAN; NASDAQ:SNY). Microbiome company Evolve BioSystems Inc....
...patients to predict clinical outcomes. Robin Sawka, BioCentury Staff Moderna Inc. La Jolla Pharmaceutical Co. Editas Medicine Inc. Veracyte Inc. Merus N.V. Evolve BioSystems Inc. Mindera...
Items per page:
1 - 1 of 1
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...Andres Sirulnik as CMO. Joe was a VP of oncology Sanofi (Euronext:SAN; NASDAQ:SNY). Microbiome company Evolve BioSystems Inc....
...patients to predict clinical outcomes. Robin Sawka, BioCentury Staff Moderna Inc. La Jolla Pharmaceutical Co. Editas Medicine Inc. Veracyte Inc. Merus N.V. Evolve BioSystems Inc. Mindera...
Items per page:
1 - 1 of 1